Planning guidance for immunization clinics for COVID-19 vaccines

LINK

"The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic." - Planning guidance for immunization clinics for COVID-19 vaccines

Web link

Related Resources

Bookmark

Implementation Tool

Link

Published: 2021 Region: National Audience: Policy Makers, Health Care Professional Product Type: Guide Language: English Population: Children (All), Adults, Healthcare Personnel Organization: Public Health Agency of Canada (PHAC)

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

Planning guidance for immunization clinics for COVID-19 vaccines

Implementation Tool

Category

0 Comments

Make the most of the CANVax community. Join today!

The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)

Planning guidance for immunization clinics for COVID-19 vaccines

Implementation Tool

Category

0 Comments

COVID-19 Vaccine for Kids Under 5

Summary of National Advisory Committee on Immunization (NACI) Statement of June 29, 2022 : Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada

Summary of National Advisory Committee on Immunization (NACI) Statement of July 14, 2022 : Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age

COVID-19 vaccine uptake and intention during pregnancy in Canada

Communicating About Vaccines – COVID-19 & More

Monkeypox: Vaccination clinic resources

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022

National Advisory Committee on Immunization (NACI) : Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada

Create an account

Create an account

Resource Rating Breakdown

The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)